Andere Sprachen Mycenax Biotech Inc.

Aktien

4726

TW0004726005

4726

Schlusskurs Taipei Exchange Andere Börsenplätze 00:00:00 14.05.2024			% 5 Tage	% 1. Jan.
44,25 ^TWD	+1,14 %		-4,01 %	+23,95 %

14.03.	Mycenax Biotech Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
13.03.	Mycenax Biotech Inc. kündigt die Ernennung von Li-Ju Yeh zum Corporate Governance Officer an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14.03.
Mycenax Biotech Inc. Announces the Appointment of Li-Ju Yeh as Corporate Governance Officer	13.03.
Mycenax Biotech Inc. cancelled the transaction announced on March 13, 2023	13.03.
Mycenax Biotech Inc. announced that it expects to receive funding from Center Laboratories, Inc., JCR Pharmaceuticals Co., Ltd., Taiwan BioVenture Company, Jason Technologies Ltd	13.03.
Mycenax Biotech Inc. Announces Resignation of Stacy Sun as Corporate Governance Officer, Effective on February 29, 2024	27.02.
Mycenax Biotech Inc. Announces Board Changes	19.02.
Mycenax Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.
Mycenax Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11.08.23
Mycenax Biotech Inc. Announces Resignation of Yu-Ching Chang as Financial and Accounting Officer, Effective on August 11, 2023	02.08.23
Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12.05.23
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14.03.23
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14.03.23
Mycenax Biotech Inc. announced a financing transaction	13.03.23
Mycenax Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11.11.22
Mycenax Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12.08.22
Mycenax Biotech Inc. announced that it expects to receive TWD 1.659112761 billion in funding from JCR Pharmaceuticals Co., Ltd., Center Laboratories, Inc.	27.07.22
Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	14.05.22
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	24.03.22
Mycenax Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12.11.21
Mycenax Biotech Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	14.08.21

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Mycenax Biotech Inc.

Aktien

4726

TW0004726005

4726

Andere Sprachen

Filter